Literature DB >> 22969910

Synchronous and metachronous lung metastases in patients with colorectal cancer: A 20-year monocentric experience.

Hiroaki Nozawa1, Eiji Sunami, Jun Nakajima, Hirokazu Nagawa, Joji Kitayama.   

Abstract

There is little information regarding the recent trend of synchronous and metachronous pulmonary metastases in patients with primary colorectal cancer. We investigated patients with sporadic colorectal cancer who underwent surgery in our department between 1990 and 2009. Clinicopathological parameters of primary cancer and lung metastases and survival time were retrospectively reviewed. Of the 2,286 patients included in this study, 64 (2.8%) had synchronous lung metastases at the time of colorectal surgery. A total of 18 patients (28%) received pulmonary metastasectomy for these lesions with curative intent. Out of 2,082 curatively operated cases, 212 (10.2%) developed metachronous lung metastases. The frequency of synchronous and/or metachronous lung metastases detected in curative cases increased from 8.9% in the 1990s to 11.9% in the 2000s (p=0.03). Among predictive factors for metachronous lung metastases, the presence of distant organ metastases, i.e. initial stage IV, significantly increased over time. Notably, patients with unresectable metachronous lung metastases in the 2000s, characterized by smaller size, exhibited more favorable prognosis than in the 1990s (p=0.003). Recent improvement of imaging modalities is considered to have facilitated the prompt diagnosis of lung metastases. Moreover, marked progress in multidisciplinary treatment has presumably achieved more favorable prognosis in an increasing number of patients with advanced colorectal cancer.

Entities:  

Year:  2011        PMID: 22969910      PMCID: PMC3438797          DOI: 10.3892/etm.2011.443

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  16 in total

1.  Patterns of recurrence after curative resection of carcinoma of the colon and rectum.

Authors:  S Galandiuk; H S Wieand; C G Moertel; S S Cha; R J Fitzgibbons; J H Pemberton; B G Wolff
Journal:  Surg Gynecol Obstet       Date:  1992-01

2.  Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project.

Authors:  Tomohiro Matsuda; Tomomi Marugame; Ken-ichi Kamo; Kota Katanoda; Wakiko Ajiki; Tomotaka Sobue
Journal:  Jpn J Clin Oncol       Date:  2010-09-06       Impact factor: 3.019

3.  Estimates of cancer incidence and mortality in Europe in 2008.

Authors:  J Ferlay; D M Parkin; E Steliarova-Foucher
Journal:  Eur J Cancer       Date:  2010-01-29       Impact factor: 9.162

4.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

5.  Surgical management of pulmonary metastases from colorectal cancer in 153 patients.

Authors:  Süleyman Yedibela; Peter Klein; Karsta Feuchter; Martin Hoffmann; Thomas Meyer; Thomas Papadopoulos; Jonas Göhl; Werner Hohenberger
Journal:  Ann Surg Oncol       Date:  2006-09-29       Impact factor: 5.344

Review 6.  Colorectal cancer.

Authors:  David Cunningham; Wendy Atkin; Heinz-Josef Lenz; Henry T Lynch; Bruce Minsky; Bernard Nordlinger; Naureen Starling
Journal:  Lancet       Date:  2010-03-20       Impact factor: 79.321

7.  Prognostic factors in resection of pulmonary metastasis from colorectal cancer.

Authors:  I Watanabe; T Arai; M Ono; M Sugito; K Kawashima; M Ito; K Nagai; N Saito
Journal:  Br J Surg       Date:  2003-11       Impact factor: 6.939

8.  Lung metastases from colorectal cancer: surgical resection and prognostic factors.

Authors:  Nuno Rama; Alexandre Monteiro; João E Bernardo; Luís Eugénio; Manuel J Antunes
Journal:  Eur J Cardiothorac Surg       Date:  2009-01-10       Impact factor: 4.191

9.  Factors influencing survival after complete resection of pulmonary metastases from colorectal cancer.

Authors:  K Watanabe; K Nagai; A Kobayashi; M Sugito; N Saito
Journal:  Br J Surg       Date:  2009-09       Impact factor: 6.939

10.  Pulmonary resection for metastases from colorectal cancer: factors influencing prognosis. Twenty-year experience.

Authors:  Ottavio Rena; Caterina Casadio; Franco Viano; Riccardo Cristofori; Enrico Ruffini; Pier Luigi Filosso; Giuliano Maggi
Journal:  Eur J Cardiothorac Surg       Date:  2002-05       Impact factor: 4.191

View more
  8 in total

1.  Clinical outcomes of Chinese patients with metastatic colorectal cancer receiving first-line bevacizumab-containing treatment.

Authors:  Long Bai; Dong-Sheng Zhang; Wen-Jing Wu; Chao Ren; De-Shen Wang; Feng Wang; Miao-Zhen Qiu; Rui-Hua Xu
Journal:  Med Oncol       Date:  2015-01-13       Impact factor: 3.064

2.  Predictors and outcome of complete removal of colorectal cancer with synchronous lung metastases.

Authors:  Hiroaki Nozawa; Junichiro Tanaka; Takeshi Nishikawa; Toshiaki Tanaka; Tomomichi Kiyomatsu; Kazushige Kawai; Keisuke Hata; Shinsuke Kazama; Hironori Yamaguchi; Soichiro Ishihara; Eiji Sunami; Joji Kitayama; Jun Nakajima; Norihiro Kokudo; Toshiaki Watanabe
Journal:  Mol Clin Oncol       Date:  2015-07-08

3.  Metadherin expression and lung relapse in patients with colorectal carcinoma.

Authors:  Sandra Casimiro; Afonso Fernandes; António Gouveia Oliveira; Marco Franco; Ricardo Pires; Mafalda Peres; Margarida Matias; Joana Tato-Costa; Nuno Guerra; Madalena Ramos; Jorge Cruz; Luis Costa
Journal:  Clin Exp Metastasis       Date:  2014-06-20       Impact factor: 5.150

4.  Patients with colorectal lung oligometastases (L-OMD) treated by dose adapted SABR at diagnosis of oligometastatic disease have better outcomes than patients previously treated for their metastatic disease.

Authors:  Alina Mihai; Yijia Mu; John Armstrong; Mary Dunne; Sushil Beriwal; Luke Rock; Pierre Thirion; Dwight E Heron; Brian Healy Bird; Jennifer Westrup; Conleth Gerard Murphy; M Saiful Huq; Raymond McDermott
Journal:  J Radiosurg SBRT       Date:  2017

5.  Progress in rectal cancer treatment.

Authors:  Wim P Ceelen
Journal:  ISRN Gastroenterol       Date:  2012-08-30

6.  Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-adapted dose prescription with a maximum dose of 83-100 Gy in five fractions.

Authors:  Atsuya Takeda; Naoko Sanuki; Yuichiro Tsurugai; Yohei Oku; Yousuke Aoki
Journal:  J Radiat Res       Date:  2016-03-16       Impact factor: 2.724

7.  Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.

Authors:  Jon-Helge Angelsen; Asgaut Viste; Inger Marie Løes; Geir Egil Eide; Dag Hoem; Halfdan Sorbye; Arild Horn
Journal:  World J Surg Oncol       Date:  2015-12-03       Impact factor: 2.754

8.  Emergency resection surgery for colorectal cancer: Patterns of recurrent disease and survival.

Authors:  Joe Littlechild; Muneer Junejo; Anne-Marie Simons; Finlay Curran; Darren Subar
Journal:  World J Gastrointest Pathophysiol       Date:  2018-02-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.